PASITHEA THERAPEUTICS ANNOUNCES POSITIVE PAS-004 CLINICAL DATA FROM PHASE 1 ADVANCED CANCER STUDY PRESENTED AT ESMO CONGRESS 2026

Reuters · 2d ago

Please log in to view news